NEW YORK (GenomeWeb) – Horizon Discovery today announced an agreement with Swift Biosciences to incorporate Horizon's human genomic reference standards into Swift's Accel-Amplicon 56G Oncology Panel.

Swift will include Horizon's HDx Quantitative Multiplex Reference Standard material as a positive control in its single-tube, 56-gene panel. The assay covers genes clinically relevant to cancer and generates sequencing libraries for use on common next-generation sequencing platforms from both formalin-fixed, paraffin-embedded and circulating, cell-free DNA samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.